Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to assess the safety and efficacy of two doses of IV
palonosetron each administered as a single dose for the prevention of postoperative nausea
and vomiting through 72 hours postoperatively in children aged 28 days up to 16 years
inclusive undergoing surgical procedures requiring general endotracheal inhalation
anesthesia.